US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 23.050
  • -1.520-6.19%
Close May 22 16:00 ET
676.51MMarket Cap-7842P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-45.28%-14.94M
-26.80%-36.86M
-33.93%-11.85M
-10.28M
-193.52%-29.07M
-8.85M
-9.9M
Net income from continuing operations
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
---7.09M
-117.22%-28.48M
---10.12M
---13.11M
Depreciation and amortization
32.10%107K
141.50%355K
110.20%103K
--81K
--147K
--49K
--0
Change In working capital
18.37%-2.82M
394.13%4.86M
-244.16%-1.59M
---3.45M
-152.61%-1.65M
--1.11M
--3.14M
-Change in receivables
-134.13%-398K
223.98%5.16M
123.70%273K
--1.17M
-181.98%-4.16M
---1.15M
---1.48M
-Change in prepaid assets
107.76%241K
119.49%123K
-1,148.92%-2.42M
--116K
-132.84%-631K
--231K
---271K
-Change in payables and accrued expense
36.86%-2.99M
-71.01%661K
-21.07%1.6M
---4.73M
-53.65%2.28M
--2.03M
--4.92M
-Change in other current assets
6,760.00%343K
-3,212.90%-1.03M
-5,861.11%-1.04M
--5K
-3.33%-31K
--18K
---30K
-Change in other working capital
-88.89%-17K
-106.17%-55K
60.87%-9K
---9K
--891K
---23K
----
Cash from discontinued investing activities
Operating cash flow
-45.28%-14.94M
-26.80%-36.86M
-33.93%-11.85M
---10.28M
-193.52%-29.07M
---8.85M
---9.9M
Investing cash flow
Cash flow from continuing investing activities
-130.37%-5.51M
133.86%20.25M
34.96%-8.24M
18.13M
-181,169.70%-59.82M
-12.67M
-33K
Capital expenditure reported
-128.57%-32K
20.86%-110K
65.52%-10K
---14K
-321.21%-139K
---29K
---33K
Net investment purchase and sale
-130.17%-5.48M
134.12%20.36M
34.89%-8.23M
--18.15M
---59.68M
---12.64M
--0
Cash from discontinued investing activities
Investing cash flow
-130.37%-5.51M
133.86%20.25M
34.96%-8.24M
--18.13M
-181,169.70%-59.82M
---12.67M
---33K
Financing cash flow
Cash flow from continuing financing activities
217.85M
38.17%133.57M
-4.87M
0
548.31%96.68M
0
14.91M
Net issuance payments of debt
--0
--0
--0
--0
--0
--0
----
Net common stock issuance
--230M
--72M
--0
--0
--0
--0
----
Net preferred stock issuance
----
--0
--0
----
566.67%100M
--0
--15M
Proceeds from stock option exercised by employees
--271K
--5K
--0
--0
--0
--0
----
Net other financing activities
---12.42M
1,952.26%61.57M
---4.87M
----
-3,677.27%-3.32M
--0
---88K
Cash from discontinued financing activities
Financing cash flow
--217.85M
38.17%133.57M
---4.87M
--0
548.31%96.68M
--0
--14.91M
Net cash flow
Beginning cash position
758.29%132.39M
101.95%15.43M
325.94%157.35M
--15.43M
186.82%7.64M
--36.94M
--2.66M
Current changes in cash
2,415.60%197.4M
1,402.07%116.97M
-15.99%-24.96M
--7.85M
56.52%7.79M
---21.52M
--4.98M
End cash Position
1,317.11%329.79M
758.29%132.39M
758.29%132.39M
--23.27M
101.95%15.43M
--15.43M
--7.64M
Free cash flow
-45.40%-14.97M
-26.57%-36.97M
-33.60%-11.86M
---10.3M
-193.94%-29.21M
---8.88M
---9.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -45.28%-14.94M-26.80%-36.86M-33.93%-11.85M-10.28M-193.52%-29.07M-8.85M-9.9M
Net income from continuing operations -93.93%-13.75M-52.95%-43.56M-4.42%-10.56M---7.09M-117.22%-28.48M---10.12M---13.11M
Depreciation and amortization 32.10%107K141.50%355K110.20%103K--81K--147K--49K--0
Change In working capital 18.37%-2.82M394.13%4.86M-244.16%-1.59M---3.45M-152.61%-1.65M--1.11M--3.14M
-Change in receivables -134.13%-398K223.98%5.16M123.70%273K--1.17M-181.98%-4.16M---1.15M---1.48M
-Change in prepaid assets 107.76%241K119.49%123K-1,148.92%-2.42M--116K-132.84%-631K--231K---271K
-Change in payables and accrued expense 36.86%-2.99M-71.01%661K-21.07%1.6M---4.73M-53.65%2.28M--2.03M--4.92M
-Change in other current assets 6,760.00%343K-3,212.90%-1.03M-5,861.11%-1.04M--5K-3.33%-31K--18K---30K
-Change in other working capital -88.89%-17K-106.17%-55K60.87%-9K---9K--891K---23K----
Cash from discontinued investing activities
Operating cash flow -45.28%-14.94M-26.80%-36.86M-33.93%-11.85M---10.28M-193.52%-29.07M---8.85M---9.9M
Investing cash flow
Cash flow from continuing investing activities -130.37%-5.51M133.86%20.25M34.96%-8.24M18.13M-181,169.70%-59.82M-12.67M-33K
Capital expenditure reported -128.57%-32K20.86%-110K65.52%-10K---14K-321.21%-139K---29K---33K
Net investment purchase and sale -130.17%-5.48M134.12%20.36M34.89%-8.23M--18.15M---59.68M---12.64M--0
Cash from discontinued investing activities
Investing cash flow -130.37%-5.51M133.86%20.25M34.96%-8.24M--18.13M-181,169.70%-59.82M---12.67M---33K
Financing cash flow
Cash flow from continuing financing activities 217.85M38.17%133.57M-4.87M0548.31%96.68M014.91M
Net issuance payments of debt --0--0--0--0--0--0----
Net common stock issuance --230M--72M--0--0--0--0----
Net preferred stock issuance ------0--0----566.67%100M--0--15M
Proceeds from stock option exercised by employees --271K--5K--0--0--0--0----
Net other financing activities ---12.42M1,952.26%61.57M---4.87M-----3,677.27%-3.32M--0---88K
Cash from discontinued financing activities
Financing cash flow --217.85M38.17%133.57M---4.87M--0548.31%96.68M--0--14.91M
Net cash flow
Beginning cash position 758.29%132.39M101.95%15.43M325.94%157.35M--15.43M186.82%7.64M--36.94M--2.66M
Current changes in cash 2,415.60%197.4M1,402.07%116.97M-15.99%-24.96M--7.85M56.52%7.79M---21.52M--4.98M
End cash Position 1,317.11%329.79M758.29%132.39M758.29%132.39M--23.27M101.95%15.43M--15.43M--7.64M
Free cash flow -45.40%-14.97M-26.57%-36.97M-33.60%-11.86M---10.3M-193.94%-29.21M---8.88M---9.94M
Currency Unit USDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg